Evidence map›Paper›PMID 20937835›Full record

ArticleThe Journal of biological chemistry2010

Peptidylarginine deiminase 2 suppresses inhibitory {kappa}B kinase activity in lipopolysaccharide-stimulated RAW 264.7 macrophages.

Hye Jeong Lee, Myungsoo Joo, Rasul Abdolrasulnia, David G Young, Inyeong Choi, Lorraine B Ware, Timothy S Blackwell, Brian W Christman

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Hye Jeong LeeDivision of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, Vanderbilt University, Nashville, Tennessee 37232, USA. hye-jeong.lee@vanderbilt.edu
Myungsoo Joo
Rasul Abdolrasulnia
David G Young
Inyeong Choi
Lorraine B Ware
Timothy S Blackwell
Brian W Christman
Vanderbilt University · USEmory University · US

Funding

Role of Eicosanoids In Modulating Endotoxin Induced LiveP01HL066196 · NHLBI · VANDERBILT UNIVERSITY · PI CAPRIOLI, RICHARD M · 2002 to 2006
$9.0M
Biomarker Profiles in the Diagnosis/Prognosis of ARDSU01HL081332 · NHLBI · VANDERBILT UNIVERSITY · PI WARE, LORRAINE B · 2005 to 2008
$6.0M
Treatment of Pulmonary Edema in Organ DonorsR01HL088263 · NHLBI · VANDERBILT UNIVERSITY · PI WARE, LORRAINE B · 2008 to 2012
$2.3M
Midcareer Investigator Award in Patient-Oriented Research in Acute Lung InjuryK24HL103836 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI WARE, LORRAINE B · 2010 to 2020
$1.6M
Structure/function analysis of the na/bicarbonate cotransportersR01GM078502 · NIGMS · EMORY UNIVERSITY · PI CHOI, INYEONG · 2007 to 2011
$1.6M
NHLBI NIH HHS HL088263NHLBI NIH HHS HL81332NHLBI NIH HHS K24 HL103836NHLBI NIH HHS P01 HL066196NHLBI NIH HHS P01 HL66196NHLBI NIH HHS R01 HL088263NHLBI NIH HHS U01 HL081332NIGMS NIH HHS R01 GM078502NIGMS NIH HHS R01-GM078502
6 · The paper itself

Abstract

Peptidylarginine deiminases (PADs) are enzymes that convert arginine to citrulline in proteins. In this study, we examined PAD-mediated citrullination and its effect on pro-inflammatory activity in the macrophage cell line RAW 264.7. Citrullination of 45-65-kDa proteins was induced when cells were treated with lipopolysaccharide (LPS; 1 μg/ml). Protein citrullination was suppressed by the intracellular calcium chelator BAPTA/AM (30 μM). LPS treatment up-regulated COX-2 levels in cells. Interestingly, overexpressing PAD2 reduced LPS-mediated COX-2 up-regulation by 50%. PAD2 overexpression also reduced NF-κB activity, determined by NF-κB-driven luciferase activity. The effect of PAD2 on NF-κB activity was further examined by using HEK 293 cells transfected with NF-κB luciferase, IκB β/γ kinase (IKKβ/γ) subunits, and PAD2. IKKβ increased NF-κB activity, but this increase was markedly suppressed when PAD2 was present in cells. IKKβ-mediated NF-κB activation was further enhanced by IKKγ in the presence of calcium ionophore A23187. However, this stimulatory effect of IKKβ/γ was abolished by PAD2. Coimmunoprecipitation of cell lysates showed that IKKγ and PAD2 can coimmunoprecipitate in the presence of the Ca(2+) ionophore. IKKγ coimmunoprecipitated truncation mutants, PAD2(1-385) and PAD2(355-672). The substitution of Gln-358 (a putative ligand for Ca(2+) binding) with an Ala abolished coimmunoprecipitation. Conversely, PAD2 coimmunoprecipitated truncation mutants IKKγ(1-196) and IKKγ(197-419). In other experiments, treating RAW 264.7 cells with LPS induced citrullination in the immunoprecipitates of IKKγ. In vitro citrullination assay showed that incubation of purified PAD2 and IKKγ proteins in the presence of Ca(2+) citrullinated IKKγ. These results demonstrate that PAD2 interacts with IKKγ and suppresses NF-κB activity.

Indexed as

AnimalsCalcimycinChelating AgentsCitrullineCyclooxygenase 2Egtazic AcidHEK293 CellsHumansHydrolasesI-kappa B KinaseIonophoresLipopolysaccharidesMiceMutationNF-kappa BProtein-Arginine Deiminases1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acidCalcimycinChelating AgentsCitrullineCyclooxygenase 2Egtazic AcidHydrolasesI-kappa B KinaseIonophoresLipopolysaccharidesNF-kappa BPADI2 protein, humanProtein-Arginine DeiminasesProtein-Arginine Deiminase Type 2Ptgs2 protein, mouse

Identifiers

PMID20937835
PMCPMC3000946
OpenAlexW2004819781

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.